當前位置：   首頁 > 需求大廳

1、Arzneimittelforschung. 1985;35(7A):1203-8. Ohashi S, Iwatani M, Hyakuna Y, Morioka Y. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion. 2、Arzneimittelforschung. 1985;35(7A):1149-54. K Kawamura, K Watanabe, Y Kimura. Effect of cilostazol, a new antithrombotic drug, on cerebral circulation 3、Gel formation of cefpodoxime proxetil 4、Gas chromatographic analysis of fosfomycin in plasma for pharmacokinetic analysis. GK Webster, RG Bell - Journal of AOAC International, 1999 - europepmc.org 5、Rydell N, Butler J, Balazs EA. Hyaluronic acid in synovial fluid.Ⅵ. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of the arthritis in track horses. Acta Vet Scand, 1970,11:139~146 6、Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol, 1974, 22:731~736 7、Weiss C, Balazs EA, St Onge R, et al. Clinical studies of the intra-articular injection of Healon in the treatment of osteoarthritis of human knee. Semin Arhtritis Rheum, 1980, 11(Suppl 1):143~144 8、Punzi L, Schiavon F, Ramonda R, et al. Intra-articular hyaluronic acid in the treatment of inflammatory and non-inflammatory knee diffusions. Curr Ther Res, 1988, 43:643~647 9、Nolan JP, reducing Catheter Related Bacteraemia in Haemodialysis. Vascular Access Soc. 5th Int. Congress of Vascular Access Soc, Nice, 2007 10、Arzneimittelforschung. 1984;34(9):948-52. Iron derivatives of modified milk protein.   [更多]

每篇文獻完整，清晰   [更多]

需求內容在圖片里面   [更多]

求混合糖電解質注射液的IMS全球銷售數(shù)據(jù)，日本的商品名：TRIFLUID Injection   [更多]

文獻： 1、" Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. " Pharmacotherapy 2007;27:290–8. Page RL, Schwiesow J, Hilts A. 2、Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013;39:310–24. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al. 3、Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A. Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99. 4、J Med Chem, 51: 4632～4640. Org. Process Res. Dev. 2019, 23, 9, 2057-2068 Pharmazie 73(9):494-497 · September 2018 5、中國醫(yī)藥工業(yè)雜志 2012， 43（8）， 644-646 6、精細化工中間體2013，43（2），46-48 7、精細化工中間體2011，41（4），46-48 8、中國現(xiàn)代應用藥學2011，28（1），58-59 9、Chemical biology&Drug Design 2014, 83(3), 306-316 10、Letters in organic chemistry 2012, 9(4), 276-279 11、Medicines Evidence Commentary : Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders Source: National Institute for Health and Care Excellence - NICE - 21 January 2014 - Publisher: National Institute for Health and Care Excellence (NICE) 12、double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children 13、J. Med. Chem. 2018, 61, 5304?5322. 14、Chem. Biol. Drug Des. 2014, 83, 306?316. 15、J. Pharm. Biomed. Anal. 2009, 50, 144?150. 16、Int. J. Pharm. Sci. 2016, 8, 97?102. 17、J. Pharm. Biomed. Anal. 2010, 52, 493?507. 18、Org. Process Res. Dev. 2013, 17, 1036?1041. 19、Beilstein J. Org. Chem. 2011, 7, 442? 495. 20、Bioorg. Med. Chem. Lett. 2014, 24, 1108?1110. 21、New Activated PEG Derivatives for Affinity Partitioning 22、Population incidence and mortality of sepsis in an urban African setting 2013-2016 23、Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in   [更多]

求購“ Dried Aluminium Hydroxide”《 BP2019 》的藥典標準，"Magnesium Trisilicate" USP42 BP2019 EP9.2等最新標準   [更多]

1.根據(jù)提供的PDF文件以及文檔需求，整理出需要的字段內容，要保證內容的準確性 2.共計6個數(shù)據(jù)包，完成情況好的任務者可以領取多次 3.工作內容，有點類似http://www.sdcbcs.com/shuju/13820.html   [更多]

求購“Sodium Valproate Tablets”BP2020 “Divalproex Sodium Delayed-Release Tablets”USP42 ； USP42版通則部分（191）、（921）、（221）、（211）；BP2020版通則部分（2.3.1）、（2.4.4）、（2.4.13）、（2.4.2）、（2.5.11）、（2.2.1）、（2.2.2）、（2.2.3）、（2.9.31）、（2.9.26）   [更多]

求購“Sodium Valproate Tablets”BP2020 ；BP2020版通則部分（2.3.1）、（2.4.4）、（2.4.13）、（2.4.2）、（2.5.11）、（2.2.1）、（2.2.2）、（2.2.3）、（2.9.31）、（2.9.26）   [更多]

求購“Alumina and Magnesium Trisilicate Tablets”-USP42、Compound Magnesium Trisilicate Tablets-BP2020、Chewable Compound Magnesium Trisilicate Tablets-BP2020、Chewable Aluminium Hydroxide Tablets-BP2020、Chewable Aluminium Hydroxide and Magnesium Trisilicate Tablets-BP2020等最新藥典。   [更多]